| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/09/1997 | WO1997016172A1 Controlled release formulation (albuterol) |
| 05/09/1997 | WO1997016170A1 Treatment of a coronary condition by delivery of therapeutics to the pericardial space |
| 05/09/1997 | WO1997016169A1 Treatment of a cardiovascular indication by delivery of therapeutics to the pericardial space |
| 05/09/1997 | WO1997016166A1 Skin care preparation and method |
| 05/09/1997 | WO1997016165A1 Use of carboxylic acids having a sulphur function for promoting skin exfoliation or stimulating epidermal regeneration |
| 05/09/1997 | WO1997016155A2 Cosmetic and cosmeceutical compositions |
| 05/09/1997 | WO1997016068A1 Triterpene derivatives with immunosuppressant activity |
| 05/09/1997 | WO1997006769A3 Pharmaceutical composition with trypanocidal properties |
| 05/09/1997 | CA2237607A1 Triterpene derivatives with immunosuppressant activity |
| 05/09/1997 | CA2236760A1 Cosmetic and cosmeceutical compositions |
| 05/09/1997 | CA2236604A1 Antithrombotic n-amidinopiperidine and benzamidine derivatives |
| 05/09/1997 | CA2236419A1 Neurogenic differentiation (neurod) genes and proteins |
| 05/09/1997 | CA2236328A1 Rotamase enzyme activity inhibitors |
| 05/09/1997 | CA2236297A1 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 05/09/1997 | CA2236175A1 New technology for wet granulation |
| 05/09/1997 | CA2236171A1 Triterpene derivatives with immunosuppressant activity |
| 05/09/1997 | CA2236111A1 Protease inhibitors |
| 05/09/1997 | CA2235994A1 Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the novel compounds |
| 05/09/1997 | CA2235886A1 Triterpene derivatives with immunosuppressant activity |
| 05/09/1997 | CA2235858A1 Triterpene derivatives with immunosuppressant activity |
| 05/09/1997 | CA2235603A1 Methods and compositions using butyrate esters of threitol |
| 05/09/1997 | CA2235598A1 Novel nucleoside derivatives and process for preparing the same |
| 05/09/1997 | CA2235584A1 24-homo-26,27-hexafluoro-cholecalciferols |
| 05/09/1997 | CA2234701A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use |
| 05/09/1997 | CA2234641A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 05/09/1997 | CA2234102A1 Genetic induction of receptors for targeted radiotherapy |
| 05/09/1997 | CA2234081A1 Processes and intermediates for preparing 1-(2-[2-isoxazol-3-ylbenzofuran-5-yloxy]ethylamino)-3-phenoxy-2(s)-ol |
| 05/09/1997 | CA2233250A1 Use of protein gax for treating cancer |
| 05/09/1997 | CA2232355A1 Thiamorphinans with neuroprotective activity |
| 05/09/1997 | CA2209109A1 Method of inhibiting cathepsin k |
| 05/08/1997 | CA2499302A1 Dna-based vaccination of fish by immersion |
| 05/07/1997 | EP0771818A2 Biotin derivatives |
| 05/07/1997 | EP0771816A2 Isomerisation of equilin |
| 05/07/1997 | EP0771815A1 Sulfated and phosphated saccharide derivatives, process for the preparation of the same and use thereof |
| 05/07/1997 | EP0771813A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxydes and their use as medicines |
| 05/07/1997 | EP0771803A1 Pyrazolo(1,5-a)pyrimidinium substituted cephem derivatives, their preparation and their use as antimicrobial agents |
| 05/07/1997 | EP0771801A1 Chromane derivatives |
| 05/07/1997 | EP0771800A2 Dioxino derivatives and their use as dopamine agonists |
| 05/07/1997 | EP0771799A1 Purin-6-one derivatives |
| 05/07/1997 | EP0771798A1 Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation methods and compositions containing them |
| 05/07/1997 | EP0771795A1 New glycomimetics as Selectin antagonists, and anti-imflammation pharmaceutical compositions |
| 05/07/1997 | EP0771791A1 Ethylamino carbazole melatonergic agents |
| 05/07/1997 | EP0771790A1 Process for preparing 1-substituted pyrrole-3-carboxylic acid derivatives |
| 05/07/1997 | EP0771789A1 1 alpha, 26-dihydroxy-D-homo-vitamin D3 |
| 05/07/1997 | EP0771788A2 Substituted sulphonimidamides, method for their preparation, their use as medicament or diagnostic and medicament containing them |
| 05/07/1997 | EP0771563A2 Use of 5-HTiA receptor ligands for the treatment of glaucoma |
| 05/07/1997 | EP0771562A2 Improved preparation for colonic evacuation |
| 05/07/1997 | EP0771561A2 Antimycotic compositions, especially active against dandruff, containing aromatic alcohols |
| 05/07/1997 | EP0771560A1 Use of 2- N-(1,2-benzoisothiazolyl-3(2H)one-1,1-dioxide ethyl 5-ethoxycarbonyl-2,4,6-trimethyl-1,4-dihydropiridine-3-carboxylate in the treatment of vascular disorders |
| 05/07/1997 | EP0771557A1 Use of ascorbic acid as the actif for the treatment of seborrhea in a cosmetic and/or dermatalogical composition |
| 05/07/1997 | EP0771555A2 Agent for external application with nutrient and protective properties |
| 05/07/1997 | EP0771217A1 Solid drug forms containing clathrates of steroid sex hormones |
| 05/07/1997 | EP0771209A2 Novel peptides |
| 05/07/1997 | EP0771206A1 Hard tissue stimulating agent |
| 05/07/1997 | EP0771204A1 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides |
| 05/07/1997 | EP0771203A1 Method of treating sweat-related conditions |
| 05/07/1997 | EP0771202A1 USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) AND ITS PHYSIOLOGICALLY COMPATIBLE SALTS FOR TREATING REPERFUSION DAMAGE TRIGGERED BY TEMPORARY FOCAL ISCHAEMIA |
| 05/07/1997 | EP0771201A1 Methods of inhibiting primary endometrial hyperplasia |
| 05/07/1997 | EP0771200A1 Methods of inhibiting viral replication |
| 05/07/1997 | EP0771199A1 Methods |
| 05/07/1997 | EP0771198A1 Dihydro-2,3-benzodiazepine derivatives |
| 05/07/1997 | EP0771197A1 Use of heterocyclic compounds as dopamines-d 3? ligands |
| 05/07/1997 | EP0771196A1 Excitatory amino acid receptor antagonists |
| 05/07/1997 | EP0771195A1 Method of inhibiting nitric oxide formation |
| 05/07/1997 | EP0771194A1 Use of droloxifene for the treatment of cardiovascular diseases |
| 05/07/1997 | EP0771193A1 Activation of growth factors by matrix vesicles |
| 05/07/1997 | EP0771192A1 Use of anti-vegf agents in the treatment of endometriosis |
| 05/07/1997 | EP0771191A1 Immunological activity of rhamnolipids |
| 05/07/1997 | EP0771189A1 Inhalation composition |
| 05/07/1997 | EP0771188A2 Soap composition |
| 05/07/1997 | EP0771187A1 Novel combination product comprising an antifungal agent and crotamiton as an antifungal activity enhancer and dermatological or cosmetic compositions comprising same |
| 05/07/1997 | EP0756479A4 Gentle anti-acne composition |
| 05/07/1997 | EP0727941A4 Methods of achieving antitumor activity using 16-membered-macrolide-type compounds |
| 05/07/1997 | EP0717744B1 A process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine |
| 05/07/1997 | EP0712398B1 Benzopyrans and pharmaceutical compositions containing them |
| 05/07/1997 | EP0684973B1 Process for the preparation of a water-dispersible carotenoid preparation in powder form |
| 05/07/1997 | EP0684951B1 Silylated acetylcholinesterase inhibitors |
| 05/07/1997 | EP0681578B1 Antiviral naphthoquinone compounds, compositions and uses thereof |
| 05/07/1997 | EP0660840B1 Phosphono substituted tetrazole derivatives |
| 05/07/1997 | EP0626956B1 Quinolylbenzofuran derivatives as leukotriene antagonists |
| 05/07/1997 | EP0593575B1 Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories |
| 05/07/1997 | EP0566571B1 Diagnosis of metastatic cancer by the mts-1 gene |
| 05/07/1997 | EP0542969B1 Biodegradable particulate vector and method of synthesis |
| 05/07/1997 | EP0482084B1 (1,2n) and (3,2n)-carbocyclic-2-amino tetralin derivatives |
| 05/07/1997 | EP0238553B1 Method of treating catabolic dysfunction |
| 05/07/1997 | DE19541283A1 Neue Aminosäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New amino acid derivatives, to processes for their preparation containing these compounds and pharmaceutical compositions |
| 05/07/1997 | DE19541260A1 Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut Therapeutic composition for transdermal administration of drugs through the skin |
| 05/07/1997 | DE19540902A1 Protein mit Anti-Tumorwirkung Protein with anti-tumor activity |
| 05/07/1997 | DE19540642A1 Use of phosphodiesterase I, IV and V inhibitors |
| 05/07/1997 | DE19540465A1 Use of monoglycerides as antimycotic agents |
| 05/07/1997 | DE19540463A1 Use of combinations for treating appearance of un-clean skin, acne etc. |
| 05/07/1997 | DE19540446A1 Tablet or capsule for encouraging waking in persons having difficulty to wake up |
| 05/07/1997 | CN1149299A Anti-GP39 antibodies and uses therefor |
| 05/07/1997 | CN1149298A An equilin double bond isomer from the acid isomerization of equilin |
| 05/07/1997 | CN1149296A Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 05/07/1997 | CN1149295A Tricyclic Dicarbonyl derivatives |
| 05/07/1997 | CN1149294A A process for preparing 1-butyl-2-[2'-(2H-tetrazol-5-YL)-biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid |
| 05/07/1997 | CN1149293A Process for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid |
| 05/07/1997 | CN1149292A Pyrimidinyl derivatives as interleukin inhibitors |
| 05/07/1997 | CN1149288A Vitamin-D amide derivatives |